GEMP - Gemphire Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Gemphire Therapeutics's activity chart (see below) currently has 4 price targets and 1 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by MATTHEW ANDREWS from on 13-Aug-2018.

Best performing analysts who are covering GEMP - Gemphire Therapeutics:

Matthew Andrews Adnan Butt Joshua Schimmer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Aug-2018

$12

8 years 3 months 9 days ago
(13-Aug-2018)

0/1 (0%)

$-9948 (-99.88%)

$30

9 years 7 months 12 days ago
(10-Apr-2017)

0/1 (0%)

$-67590 (-99.96%)

$25

10 years 2 months 23 days ago
(30-Aug-2016)

0/1 (0%)

$-67775 (-99.96%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which analyst most recently updated their price target on GEMP (Gemphire Therapeutics)?

Matthew Andrews

Which analyst has the lowest performance score on GEMP (Gemphire Therapeutics) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on GEMP (Gemphire Therapeutics)?

Matthew Andrews has 3 price targets and 3 ratings on GEMP

Which analyst is the currently most bullish on GEMP (Gemphire Therapeutics)?

Joshua Schimmer with the highest potential upside of $-1770

Which analyst is the currently most reserved on GEMP (Gemphire Therapeutics)?

Matthew Andrews with the lowest potential downside of -$1788
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?